Núria Malats

Research interests

Publications

• A faecal microbiota signature with high specificity for pancreatic cancer

  Gut · 2022 · https://doi.org/10.1136/gutjnl-2021-324755

• Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study

  Gastroenterology · 2022 · https://doi.org/10.1053/j.gastro.2022.03.054

• An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

  Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-22465-w

• A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.09.006

• Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-02942-5

• Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations

  Gut · 2017 · https://doi.org/10.1136/gutjnl-2017-314828

• GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

  Gut · 2016 · https://doi.org/10.1136/gutjnl-2015-311256

• Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

  Nature Communications · 2016 · https://doi.org/10.1038/ncomms11843

• Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data

  PLoS Genetics · 2016 · https://doi.org/10.1371/journal.pgen.1006493

• Mosaic loss of chromosome Y is associated with common variation near TCL1A

  Nature Genetics · 2016 · 10.1038/ng.3545

• Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

  Cancer Cell · 2016 · https://doi.org/10.1016/j.ccell.2016.05.004

• Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

  European Urology · 2014 · 10.1016/j.eururo.2014.06.040

• Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer

  Nature Genetics · 2014 · https://doi.org/10.1038/ng.3052

• Genome-wide association study identifies two susceptibility loci for osteosarcoma

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2645

• Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

  Nature Genetics · 2013 · 10.1038/ng.2799

• Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research

  PLoS Medicine · 2013 · https://doi.org/10.1371/journal.pmed.1001380

• Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome

  European Urology · 2013 · 10.1016/j.eururo.2013.08.052

• Detectable clonal mosaicism and its relationship to aging and cancer

  Nature Genetics · 2012 · https://doi.org/10.1038/ng.2270

• Polymorphisms in GSTT1 , GSTZ1 , and CYP2E1 , Disinfection By-products, and Risk of Bladder Cancer in Spain

  Environmental Health Perspectives · 2010 · 10.1289/ehp.1002206

• A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

  Nature Genetics · 2010 · https://doi.org/10.1038/ng.687

• Epidemiology of urinary bladder cancer: from tumor development to patient’s death

  World Journal of Urology · 2007 · 10.1007/s00345-007-0168-5

• Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas

  Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.05.1771

• A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis

  Nature Genetics · 2006 · 10.1038/ng1797

• Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools

  American Journal of Epidemiology · 2006 · https://doi.org/10.1093/aje/kwj364

• NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

  The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)67137-1

• P53 as a prognostic marker for bladder cancer: a meta-analysis and review

  The Lancet Oncology · 2005 · 10.1016/s1470-2045(05)70315-6

• EphB receptor activity suppresses colorectal cancer progression

  Nature · 2005 · https://doi.org/10.1038/nature03626

• Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage

  Clinical & Translational Oncology · 2005 · 10.1007/bf02712816

• Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

  Blood · 2004 · https://doi.org/10.1182/blood-2004-05-2058

• Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

  Journal of Clinical Oncology · 1997 · 10.1200/jco.1997.15.8.2866

Current projects

No projects listed.